Concepts (239)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Takotsubo Cardiomyopathy | 6 | 2023 | 66 | 1.570 |
Why?
|
| Obesity | 10 | 2023 | 1247 | 1.480 |
Why?
|
| Pericardium | 5 | 2023 | 35 | 1.410 |
Why?
|
| Coronary Artery Disease | 4 | 2026 | 320 | 1.360 |
Why?
|
| Atrial Fibrillation | 7 | 2026 | 854 | 1.270 |
Why?
|
| Cardiomyopathies | 4 | 2023 | 130 | 1.250 |
Why?
|
| Ventricular Remodeling | 4 | 2020 | 89 | 1.050 |
Why?
|
| Intra-Abdominal Fat | 2 | 2019 | 35 | 1.020 |
Why?
|
| Ventricular Function, Left | 4 | 2020 | 271 | 0.790 |
Why?
|
| Blood Vessels | 2 | 2014 | 63 | 0.750 |
Why?
|
| Heart Valve Diseases | 3 | 2023 | 95 | 0.740 |
Why?
|
| Adipose Tissue | 5 | 2023 | 296 | 0.720 |
Why?
|
| Electrocardiography | 7 | 2022 | 554 | 0.720 |
Why?
|
| Cardiovascular Diseases | 3 | 2014 | 848 | 0.700 |
Why?
|
| Inflammation Mediators | 2 | 2019 | 178 | 0.670 |
Why?
|
| Pheochromocytoma | 1 | 2020 | 31 | 0.660 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2020 | 47 | 0.650 |
Why?
|
| Atherosclerosis | 3 | 2016 | 156 | 0.640 |
Why?
|
| Lipolysis | 1 | 2020 | 47 | 0.630 |
Why?
|
| Diagnostic Imaging | 2 | 2013 | 266 | 0.630 |
Why?
|
| Heart Failure | 4 | 2018 | 926 | 0.620 |
Why?
|
| Echocardiography | 5 | 2023 | 509 | 0.600 |
Why?
|
| Adiposity | 2 | 2023 | 83 | 0.590 |
Why?
|
| Echocardiography, Doppler | 2 | 2018 | 133 | 0.570 |
Why?
|
| Vascular Diseases | 2 | 2016 | 82 | 0.560 |
Why?
|
| Insulin | 2 | 2020 | 684 | 0.560 |
Why?
|
| Coronary Angiography | 4 | 2026 | 209 | 0.540 |
Why?
|
| Adipocytes | 4 | 2023 | 269 | 0.520 |
Why?
|
| Adipose Tissue, Brown | 2 | 2023 | 119 | 0.500 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 1 | 2016 | 6 | 0.490 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2016 | 22 | 0.480 |
Why?
|
| Humans | 38 | 2026 | 64251 | 0.480 |
Why?
|
| Methylprednisolone | 1 | 2015 | 38 | 0.470 |
Why?
|
| Bradycardia | 1 | 2015 | 33 | 0.460 |
Why?
|
| Insulin Resistance | 2 | 2016 | 409 | 0.460 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2015 | 43 | 0.440 |
Why?
|
| Cardiac Catheterization | 2 | 2016 | 292 | 0.430 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2016 | 233 | 0.420 |
Why?
|
| Glucocorticoids | 1 | 2015 | 189 | 0.410 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2014 | 109 | 0.410 |
Why?
|
| Diastole | 3 | 2023 | 91 | 0.410 |
Why?
|
| Lectins, C-Type | 1 | 2013 | 89 | 0.390 |
Why?
|
| Inflammation | 4 | 2017 | 1162 | 0.390 |
Why?
|
| Antigens, Neoplasm | 1 | 2013 | 136 | 0.390 |
Why?
|
| Multiple Sclerosis | 1 | 2015 | 220 | 0.380 |
Why?
|
| Aortic Valve Stenosis | 2 | 2026 | 190 | 0.380 |
Why?
|
| Myocardial Infarction | 2 | 2017 | 915 | 0.380 |
Why?
|
| Outpatients | 1 | 2013 | 140 | 0.380 |
Why?
|
| Ventricular Premature Complexes | 2 | 2022 | 20 | 0.350 |
Why?
|
| Macrophages | 2 | 2016 | 1053 | 0.340 |
Why?
|
| Photoplethysmography | 3 | 2026 | 38 | 0.330 |
Why?
|
| Signal Processing, Computer-Assisted | 3 | 2026 | 101 | 0.320 |
Why?
|
| Biomarkers, Tumor | 1 | 2013 | 512 | 0.320 |
Why?
|
| Thinness | 1 | 2009 | 44 | 0.310 |
Why?
|
| Thermogenesis | 3 | 2023 | 122 | 0.300 |
Why?
|
| Male | 20 | 2026 | 30305 | 0.300 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2020 | 165 | 0.300 |
Why?
|
| Heart Failure, Diastolic | 1 | 2009 | 9 | 0.300 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2009 | 50 | 0.290 |
Why?
|
| Middle Aged | 14 | 2026 | 17906 | 0.280 |
Why?
|
| Female | 20 | 2026 | 33360 | 0.280 |
Why?
|
| Heart Atria | 3 | 2023 | 136 | 0.270 |
Why?
|
| Diet | 1 | 2011 | 533 | 0.270 |
Why?
|
| Predictive Value of Tests | 3 | 2026 | 1103 | 0.260 |
Why?
|
| Aged | 14 | 2026 | 14657 | 0.260 |
Why?
|
| Stroke Volume | 2 | 2018 | 330 | 0.250 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2019 | 544 | 0.250 |
Why?
|
| Multidetector Computed Tomography | 1 | 2026 | 26 | 0.240 |
Why?
|
| Body Mass Index | 1 | 2009 | 872 | 0.240 |
Why?
|
| Fractional Flow Reserve, Myocardial | 1 | 2026 | 21 | 0.230 |
Why?
|
| Coronary Stenosis | 1 | 2026 | 41 | 0.230 |
Why?
|
| Wearable Electronic Devices | 2 | 2026 | 79 | 0.230 |
Why?
|
| Prognosis | 4 | 2018 | 1769 | 0.230 |
Why?
|
| Histone Deacetylases | 1 | 2025 | 66 | 0.230 |
Why?
|
| Coronary Vessels | 1 | 2026 | 124 | 0.220 |
Why?
|
| Energy Metabolism | 2 | 2025 | 384 | 0.220 |
Why?
|
| Computed Tomography Angiography | 1 | 2026 | 129 | 0.220 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2026 | 158 | 0.220 |
Why?
|
| Metformin | 1 | 2025 | 74 | 0.220 |
Why?
|
| Systole | 2 | 2015 | 109 | 0.210 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2009 | 708 | 0.210 |
Why?
|
| Heart Ventricles | 3 | 2023 | 265 | 0.210 |
Why?
|
| Heart Valves | 2 | 2023 | 26 | 0.200 |
Why?
|
| Glutamine | 1 | 2023 | 49 | 0.200 |
Why?
|
| Animals | 11 | 2025 | 20961 | 0.190 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2023 | 45 | 0.190 |
Why?
|
| Fibrosis | 1 | 2023 | 162 | 0.190 |
Why?
|
| Epigenesis, Genetic | 1 | 2025 | 391 | 0.180 |
Why?
|
| Massachusetts | 4 | 2013 | 2094 | 0.180 |
Why?
|
| Myocardial Ischemia | 2 | 2017 | 117 | 0.180 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 1 | 2021 | 3 | 0.180 |
Why?
|
| Infarction, Posterior Cerebral Artery | 1 | 2021 | 7 | 0.180 |
Why?
|
| Glucose | 2 | 2023 | 470 | 0.170 |
Why?
|
| Atrial Premature Complexes | 1 | 2021 | 12 | 0.170 |
Why?
|
| Adrenergic Agents | 1 | 2020 | 15 | 0.170 |
Why?
|
| Anterior Wall Myocardial Infarction | 1 | 2020 | 7 | 0.160 |
Why?
|
| Diet, Reducing | 1 | 2020 | 27 | 0.160 |
Why?
|
| Uncoupling Protein 1 | 3 | 2020 | 50 | 0.160 |
Why?
|
| Hypertension | 1 | 2005 | 593 | 0.150 |
Why?
|
| Oxygen Consumption | 2 | 2020 | 212 | 0.150 |
Why?
|
| Subcutaneous Fat | 1 | 2019 | 47 | 0.150 |
Why?
|
| Weight Gain | 1 | 2020 | 168 | 0.150 |
Why?
|
| Muscle, Skeletal | 2 | 2023 | 747 | 0.150 |
Why?
|
| Cytokines | 3 | 2017 | 944 | 0.150 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2019 | 297 | 0.140 |
Why?
|
| Aged, 80 and over | 6 | 2026 | 5527 | 0.140 |
Why?
|
| Apolipoproteins E | 2 | 2015 | 110 | 0.140 |
Why?
|
| RNA, Long Noncoding | 1 | 2020 | 170 | 0.140 |
Why?
|
| Severity of Illness Index | 3 | 2026 | 1561 | 0.140 |
Why?
|
| Heart Rate | 3 | 2026 | 327 | 0.130 |
Why?
|
| Mice | 8 | 2025 | 11003 | 0.130 |
Why?
|
| Risk Assessment | 3 | 2018 | 2047 | 0.130 |
Why?
|
| Algorithms | 4 | 2026 | 1028 | 0.130 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2017 | 97 | 0.130 |
Why?
|
| Lectins | 1 | 2017 | 41 | 0.130 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2017 | 68 | 0.130 |
Why?
|
| Adipogenesis | 1 | 2018 | 79 | 0.130 |
Why?
|
| Prevalence | 3 | 2010 | 1407 | 0.130 |
Why?
|
| Prospective Studies | 3 | 2026 | 3316 | 0.120 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 783 | 0.120 |
Why?
|
| Stem Cells | 1 | 2018 | 262 | 0.120 |
Why?
|
| Pulse Therapy, Drug | 1 | 2015 | 4 | 0.120 |
Why?
|
| Interferon Type I | 1 | 2017 | 187 | 0.120 |
Why?
|
| Risk Factors | 4 | 2018 | 5339 | 0.120 |
Why?
|
| NADPH Oxidases | 1 | 2015 | 70 | 0.110 |
Why?
|
| Neovascularization, Physiologic | 1 | 2016 | 104 | 0.110 |
Why?
|
| Infusions, Intravenous | 1 | 2015 | 176 | 0.110 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 125 | 0.110 |
Why?
|
| Ion Channels | 2 | 2016 | 92 | 0.110 |
Why?
|
| Glucose Intolerance | 1 | 2016 | 90 | 0.110 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2016 | 151 | 0.110 |
Why?
|
| Time Factors | 3 | 2018 | 3724 | 0.110 |
Why?
|
| Mitochondrial Proteins | 2 | 2016 | 106 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 4 | 2018 | 3450 | 0.110 |
Why?
|
| Brain Ischemia | 1 | 2018 | 421 | 0.110 |
Why?
|
| Endothelial Cells | 1 | 2015 | 193 | 0.110 |
Why?
|
| Reactive Oxygen Species | 1 | 2015 | 237 | 0.110 |
Why?
|
| Lipid Metabolism | 1 | 2016 | 223 | 0.110 |
Why?
|
| Mice, Knockout | 4 | 2025 | 2140 | 0.100 |
Why?
|
| Pancreatitis-Associated Proteins | 1 | 2013 | 4 | 0.100 |
Why?
|
| Autophagy | 1 | 2016 | 231 | 0.100 |
Why?
|
| Follow-Up Studies | 3 | 2014 | 2480 | 0.100 |
Why?
|
| Blood Glucose | 1 | 2016 | 486 | 0.100 |
Why?
|
| RNA, Messenger | 2 | 2016 | 1551 | 0.100 |
Why?
|
| ROC Curve | 1 | 2013 | 288 | 0.100 |
Why?
|
| Cause of Death | 1 | 2013 | 222 | 0.090 |
Why?
|
| Treatment Outcome | 2 | 2016 | 5691 | 0.090 |
Why?
|
| Mitochondria, Heart | 1 | 2011 | 12 | 0.090 |
Why?
|
| Microarray Analysis | 1 | 2011 | 64 | 0.090 |
Why?
|
| Survival Rate | 1 | 2013 | 859 | 0.090 |
Why?
|
| Aorta, Thoracic | 1 | 2011 | 77 | 0.090 |
Why?
|
| Torsades de Pointes | 1 | 2010 | 6 | 0.090 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2011 | 136 | 0.080 |
Why?
|
| Neutrophil Infiltration | 1 | 2011 | 61 | 0.080 |
Why?
|
| Retrospective Studies | 5 | 2018 | 6732 | 0.080 |
Why?
|
| Long QT Syndrome | 1 | 2010 | 32 | 0.080 |
Why?
|
| Dietary Fats | 1 | 2011 | 175 | 0.080 |
Why?
|
| Aortic Valve | 2 | 2025 | 190 | 0.080 |
Why?
|
| Flow Cytometry | 1 | 2011 | 668 | 0.080 |
Why?
|
| Stroke | 1 | 2018 | 1196 | 0.080 |
Why?
|
| Cells, Cultured | 3 | 2020 | 2176 | 0.080 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 901 | 0.070 |
Why?
|
| Heart Failure, Systolic | 1 | 2009 | 16 | 0.070 |
Why?
|
| Cardiotonic Agents | 1 | 2009 | 54 | 0.070 |
Why?
|
| Homeostasis | 2 | 2025 | 369 | 0.070 |
Why?
|
| Disease Progression | 1 | 2013 | 1176 | 0.070 |
Why?
|
| Biomarkers | 1 | 2013 | 1431 | 0.070 |
Why?
|
| Acute Disease | 1 | 2009 | 672 | 0.070 |
Why?
|
| Odds Ratio | 1 | 2009 | 759 | 0.070 |
Why?
|
| Stress, Physiological | 1 | 2009 | 196 | 0.070 |
Why?
|
| Ultrasonography | 1 | 2009 | 486 | 0.060 |
Why?
|
| Logistic Models | 1 | 2009 | 1270 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2009 | 984 | 0.060 |
Why?
|
| Aorta | 2 | 2018 | 110 | 0.060 |
Why?
|
| Age Factors | 1 | 2009 | 1569 | 0.060 |
Why?
|
| Acetylation | 1 | 2025 | 123 | 0.060 |
Why?
|
| Hospital Mortality | 1 | 2009 | 870 | 0.060 |
Why?
|
| Stress, Psychological | 1 | 2009 | 479 | 0.050 |
Why?
|
| Extracellular Matrix | 1 | 2025 | 139 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2014 | 3070 | 0.050 |
Why?
|
| Transcatheter Aortic Valve Replacement | 1 | 2026 | 112 | 0.050 |
Why?
|
| Feasibility Studies | 1 | 2026 | 575 | 0.050 |
Why?
|
| Fibroblasts | 1 | 2025 | 404 | 0.050 |
Why?
|
| Cohort Studies | 1 | 2009 | 2604 | 0.050 |
Why?
|
| Histones | 1 | 2025 | 486 | 0.050 |
Why?
|
| Mitochondria | 1 | 2025 | 384 | 0.050 |
Why?
|
| Registries | 1 | 2026 | 885 | 0.040 |
Why?
|
| Artifacts | 1 | 2022 | 127 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 1621 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2026 | 1683 | 0.040 |
Why?
|
| Perilipin-1 | 1 | 2020 | 11 | 0.040 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2020 | 56 | 0.040 |
Why?
|
| Lipid Droplets | 1 | 2020 | 34 | 0.040 |
Why?
|
| Adult | 3 | 2026 | 17121 | 0.040 |
Why?
|
| Cell Communication | 1 | 2020 | 132 | 0.040 |
Why?
|
| Machine Learning | 1 | 2021 | 184 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2025 | 2238 | 0.030 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2017 | 53 | 0.030 |
Why?
|
| GPI-Linked Proteins | 1 | 2017 | 40 | 0.030 |
Why?
|
| Adipokines | 1 | 2017 | 32 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2018 | 218 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2020 | 632 | 0.030 |
Why?
|
| Proprotein Convertase 1 | 1 | 2016 | 7 | 0.030 |
Why?
|
| Enkephalins | 1 | 2016 | 20 | 0.030 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2016 | 18 | 0.030 |
Why?
|
| Interleukin-33 | 1 | 2016 | 18 | 0.030 |
Why?
|
| Iodide Peroxidase | 1 | 2016 | 23 | 0.030 |
Why?
|
| Cell Transplantation | 1 | 2016 | 39 | 0.030 |
Why?
|
| Capillaries | 1 | 2016 | 31 | 0.030 |
Why?
|
| Glucose Clamp Technique | 1 | 2016 | 57 | 0.030 |
Why?
|
| Receptors, LDL | 1 | 2015 | 35 | 0.030 |
Why?
|
| Integrin beta1 | 1 | 2016 | 32 | 0.030 |
Why?
|
| Adipocytes, White | 1 | 2016 | 27 | 0.030 |
Why?
|
| United States | 1 | 2009 | 7923 | 0.030 |
Why?
|
| Aminopyridines | 1 | 2015 | 36 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 2016 | 97 | 0.030 |
Why?
|
| NADPH Oxidase 4 | 1 | 2015 | 6 | 0.030 |
Why?
|
| Protein Precursors | 1 | 2016 | 85 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 234 | 0.030 |
Why?
|
| Adipocytes, Brown | 1 | 2016 | 45 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2023 | 1540 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 109 | 0.030 |
Why?
|
| Diet, High-Fat | 1 | 2016 | 176 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 209 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 518 | 0.030 |
Why?
|
| Transcriptome | 1 | 2018 | 396 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2015 | 176 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2015 | 614 | 0.030 |
Why?
|
| Phenotype | 1 | 2018 | 1222 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2015 | 471 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2015 | 304 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2015 | 576 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 708 | 0.020 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2015 | 219 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2015 | 1297 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2015 | 1001 | 0.020 |
Why?
|
| Proteins | 1 | 2016 | 760 | 0.020 |
Why?
|
| Young Adult | 1 | 2020 | 4780 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 1196 | 0.020 |
Why?
|